Stereotaxis Reports 2019 Full Year Financial Results
March 10, 2020 08:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 10, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial...
Stereotaxis Earns FDA Clearance and Announces U.S. Launch of Genesis Robotic Magnetic Navigation System
March 06, 2020 08:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 06, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today it has received...
Stereotaxis to Present at Three Investor Conferences in March
February 26, 2020 16:06 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David...
Stereotaxis to Report Fourth Quarter and Full Year 2019 Financial Results on March 10, 2020
February 26, 2020 16:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
Stereotaxis to Ring the Opening Bell® of the New York Stock Exchange
January 16, 2020 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Jan. 16, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that David...
First Patients Treated in New Robotic Arrhythmia Care Program at Overland Park Regional Medical Center
December 16, 2019 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that HCA Midwest...
Stereotaxis CEO to Present at the 12th Annual LD Micro Main Event Investor Conference
December 04, 2019 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Dec. 04, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today its Chairman and...
Stereotaxis CEO to Present at the 12th Annual BIOMEDevice San Jose Conference
November 22, 2019 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today its Chairman and...
Stereotaxis Reports 2019 Third Quarter Financial Results
November 14, 2019 08:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...
Stereotaxis and Catheter Precision Combine Robotic Navigation and Preoperative Arrhythmia Localization to Treat Cardiac Arrhythmias
November 08, 2019 09:00 ET
|
Stereotaxis, Inc.; Catheter Precision
ST. LOUIS and MT. OLIVE, N.J., Nov. 08, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE American: STXS) and Catheter Precision today announced the first patients have been successfully treated with the...